For Dihexa, no such criteria exist, because no trial has ever defined them
Patient safety and product quality is very important to us
The difference between branded Ozempic and compounded semaglutide lies primarily in sourcing and cost structure, not pharmacology
Ipamorelin is a growth hormone releasing peptide that works by stimulating the pituitary gland to produce and release more growth hormone
For Mathieu, the ideal type 1 candidate for an SGLT-2 is someone living with overweight or obesity and is not using an insulin pump (research has shown that DKA most commonly occurs in women who use insulin pumps)
Very low-calorie ketogenic diet and liraglutide as a synergistic strategy for the treatment of obesity: A short-term, non-randomised, observational, real-world clinical evaluation